<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The activation of the transcription factor NF-kappaB often results in protection against <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>In particular, pro-apoptotic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF) signals are blocked by proteins that are induced by NF-kappaB such as TNFR-associated factor 1 (TRAF1) </plain></SENT>
<SENT sid="2" pm="."><plain>Here we show that TRAF1 is cleaved after Asp-163 when cells are induced to undergo <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by Fas ligand (FasL) </plain></SENT>
<SENT sid="3" pm="."><plain>The C-terminal cleavage product blocks the induction of NF-kappaB by TNF and therefore functions as a dominant negative (DN) form of TRAF1 </plain></SENT>
<SENT sid="4" pm="."><plain>Our results suggest that the generation of DN-TRAF1 is part of a pro-apoptotic amplification system to assure rapid cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
</text></document>